WSJournal. Buybacks Rule the Day With Cash on Hand,

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

WSJournal. Buybacks Rule the Day

With Cash on Hand, Companies Invest in Their Stocks as Business Spending Slows

http://online.wsj.com/article/SB10001424127887324677204578185822803825556.html?mod=ITP_marketplace_0

Flush with record levels of cash, the biggest U.S. companies have invested hundreds of billions of dollars this year—not in new factories, but in their own stock.

[image] Bloomberg News

Safeway spent over $2 billion buying back stock this year

American companies bought back $274 billion more shares than they issued in the year through September, according to Ed Yardeni, president of investment advisory firm Yardeni Research. And the spending spree looks set to continue, a sign that companies have the cash to put to work but don't yet see an economic case for using it to expand their businesses or create jobs.

Last week, General Electric Co. GE -1.82% said it plans to buy back $10 billion of stock over the next three years. Fellow industrial conglomerate United Technologies Corp. UTX +2.83% will resume share repurchases of as much as $1 billion in 2013, and Boeing Co. BA +1.29% said it could buy back twice that.

In announcing a $1 billion acquisition Friday, paint company PPG Industries PPG +1.86% said it would spend between $500 million and $750 million buying back stock next year.

The heavy spending on stock sheds a new light on current political debates.

[image]

When executives visit Washington they argue for a negotiated solution to deficit reduction and a corporate tax overhaul to spur investment; back at headquarters they're busily sending money back to investors.

"Investing in the existing business comes first," said Mike Jackson, chief executive of AutoNation Inc., AN +0.51% the country's largest chain of car dealerships. "But you can create a lot of value when you buy stock when there are dislocations in the market."

In the past year, AutoNation spent nearly $750 million buying back stock. That took 23 million shares off the market, reducing the dealership chain's outstanding stock by 15%.

While the move consumed cash, it also boosted the company's earnings per share, a figure closely watched by investors. AutoNation's net income for the nine months ended Sept. 30 rose 10% to $233.2 million, while its earnings per share jumped 30% to $1.84.

Some of the spending on buybacks is just financial tinkering—interest rates on borrowed money are cheaper than paying dividends, so companies take on more debt to eliminate some of their shares.

But it's also an exercise that boosts per-share profits without creating more productive capacity or new jobs, revealing a lack of confidence on the part of executives to commit to new projects while the global economy remains sluggish.

Bloomberg News

IBM has one of the biggest share buyback plans

AutoNation's Mr. Jackson said the buybacks didn't come at the expense of investments in the business. In the first nine months of the year, the company's capital expenditures rose 8% to $123 million and earlier this month, the company acquired six dealerships in Texas with combined annual revenues of $575 million.

The company bought so much of its own stock because it thought the market was too pessimistic about the outlook for U.S. auto sales, Mr. Jackson said. "We felt our stock was undervalued, so we purchased aggressively, and our view played out," he said.

In fact, companies appear to be the only net buyers of U.S. listed stock this year, said Mr. Yardeni, the investment adviser. He has analyzed data from the Federal Reserve and has concluded retail investors and stock-focused mutual funds have been net sellers all year.

"Who has been buying shares?" Mr. Yardeni posed. "It has been corporations buying back their shares directly."

Safeway Inc. SWY +1.40% is a dramatic example of that dynamic. The second-largest U.S. supermarket chain spent more than $2 billion in the year to Sept. 8 buying back stock, reducing its equity base by 29%.

It paid for the program in part by borrowing $700 million last year.

The move had a big impact on the company's earnings per share for the first nine months of this year, which jumped 65%, while net income for the period only rose by 17%.

"We are still spending on capital expenditure, and we will also invest in our employees and give them more hours as sales grow," a Safeway spokeswoman said.

The supermarket chain plans $900 million in capital spending this year to open new stores, remodel others and spruce up in-store pharmacies. Last year, the company spent $1.1 billion, or about 2.5% of sales.

Capital spending by members of the Standard & Poor's 500 index had been running ahead of last year's pace, but has slowed recently, with broader business investment falling in the third quarter, according to the Commerce Department.

U.S. nonfinancial companies are sitting on more than $1.7 trillion in cash combined, according to the Federal Reserve, but they are holding back on investments in assets like building, equipment and software amid concerns about demand in key markets like China and Europe.

Honeywell International Inc., HON +2.45% for instance, expects sales growth of just 1% to 3% next year excluding the impact of acquisitions and currency movements. In announcing the outlook, Chief Financial Officer Dave Anderson described the macro environment as "challenging and uncertain."

The maker of aerospace components and turbochargers has said it is replacing just one out of every four workers who leave because of the economic and political uncertainties.

The company also recently raised its dividend and plans to buy back 5 million shares in the fourth quarter of this year and the same amount next year.

International Business Machines Corp. IBM +0.99% has one of the biggest share buyback plans. The company plans to buy back $50 billion of its own stock in the five years to 2015. In the past year, the company reduced its shares outstanding by 4.9%.

The company also plans to pay out $20 billion in dividends over the five year period.

At the same time, IBM has been making a string of small acquisitions to expand in software and has increased spending on research and development.

"Organic growth is absolutely the most valued prize," said Jim Russell, senior equity strategist at U.S. Bank Wealth Management. "That may not be viable in the slow growth economy with so much uncertainty coming out of Washington."

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nuvini Group Limited Achieves Remarkable Growth in 2024

Updated Category News Views 242

Outstanding Financial Performance Delivered by Nuvini Group NEW YORK — Nuvini Group Limited (Nasdaq: NVNI) has released its financial results for the first half of 2024, demonstrating impressive growth across various metrics. The company continues to set the bar high in the realm of private SaaS B2B acquisitions in Latin America. Growth Metrics Highlight Success The...

Continue Reading
MarketFully Expands Reach with Social Element Acquisition

Updated Category News Views 168

MarketFully Enhances Capabilities with New Acquisition Markfully, the leader in InContent Marketing, has broadened its horizons through the acquisition of a prominent global social media agency, Social Element. This strategic move is set to amplify MarketFully's capacity for delivering multilingual content marketing solutions, particularly across social media platforms....

Continue Reading
Lone Star Family Health Center Partners with athenahealth to Enhance Patient Care

Updated Category News Views 717

Lone Star Family Health Center Partners with athenahealth for Enhanced Care Lone Star Family Health Center (LSFHC), a notable health service provider, has made a major decision to transition to athenaOne, a cutting-edge suite of medical software. This strategic move aims to elevate patient care experiences and health outcomes substantially. athenahealth, well-known for...

Continue Reading
Promising Long-Term Results for Zeposia in Multiple Sclerosis

Updated Category News Views 123

Zeposia (ozanimod): A Breakthrough in Multiple Sclerosis Treatment Bristol Myers Squibb has recently shared compelling long-term findings from the Phase 3 DAYBREAK trial on Zeposia (ozanimod). This promising oral treatment has proven effective in managing relapsing forms of multiple sclerosis (MS). The results underscore Zeposia's sustained effectiveness and safety, which...

Continue Reading
Encompass Health Expands Its Rehabilitation Services in Florida

Updated Category News Views 268

Encompass Health Opens New Rehabilitation Hospital Encompass Health has recently made a significant impact in the healthcare landscape by launching a new facility. The Encompass Health Rehabilitation Hospital of St. Petersburg is now officially open to patients, marking the company's 25th location in Florida. Quality Care for Patients This facility is aimed at improving...

Continue Reading